| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |